Roi Dagan, Curtis Bryant, Zuofeng Li, Daniel Yeung, Jeb Justice, Peter Dzieglewiski, John Werning, Rui Fernandes, Phil Pirgousis, Donald C Lanza, Christopher G Morris, William M Mendenhall
PURPOSE: To report disease outcomes after proton therapy (PT) for sinonasal cancer. METHODS AND MATERIALS: Eighty-four adult patients without metastases received primary (13%) or adjuvant (87%) PT for sinonasal cancers (excluding melanoma, sarcoma, and lymphoma). Common histologies were olfactory neuroblastoma (23%), squamous cell carcinoma (22%), and adenoid cystic carcinoma (17%). Advanced stage (T3 in 25% and T4 in 69%) and high-grade histology (51%) were common...
May 1, 2016: International Journal of Radiation Oncology, Biology, Physics